関連する実験動画
Updated: Jul 15, 2026

12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
まとめ
システミック・ルプス・エリテマトーサス (SLE) 患者では10年生存率は79%で,腎炎は結果に大きく影響した. 早期の診断と治療は,SLE患者の生存率,特に若い患者の生存率を向上させる可能性があります.
科学分野:
- レウマトロジーの病理学
- 内科内科は,内科の内科である.
- ネフロロジーは腎臓科
背景:
- システミック・ルプス・エリテマトーサス (SLE) は慢性的な自己免疫疾患で,予後が変動する.
- SLEにおける長期的な生存率と予後要因を理解することは,患者の管理に極めて重要です.
- 以前の研究では,SLEにおける死亡率の有意な予測因子として腎炎が強調されています.
研究 の 目的:
- 民間SLE患者の10年生存率を評価する.
- SLEにおける生存に影響を与える予後要因を特定する.
- SLE患者のアウトカムに対する腎炎とその特徴の影響を評価する.
主な方法:
- SLEを患った609人の民間患者の長期追跡調査は,平均10年間続いた.
- 人口統計,診断のタイミング,腎炎の存在,臨床的特徴に関するデータ収集.
- 生存分析は,腎炎の状態,年齢,性別,人種に基づいて結果を比較します.
主要な成果:
- 全体の10年生存率は79% (87%は腎炎なし,65%は腎炎) でした.
- 男性SLE患者の生存率は女性より低かった.白人と非白人の有意な差はありません.
- 腎炎の発症時の腎臓症候群は予後不良の兆候であり,腎疾患と症は死亡の主な原因でした.
結論:
- 腎炎は,SLE患者の悪い予後を決定する主要な要因です.
- 腎炎の早期発見と管理,特に腎炎症候群の早期発見と管理は極めて重要です.
- 改善された生存率は,強化されたフォローアップ,栄養,早期介入戦略と関連している可能性があります.
関連する概念動画
Introduction To Survival Analysis
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
The primary goal of survival analysis is to estimate survival time—the time until a...
Survival Curves
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Assumptions of Survival Analysis
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

